Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/a-1492-2487
Achalasia and gastroparesis: Coexisting entities or consequence of therapy?
![](https://www.thieme-connect.de/media/10.1055-s-00025476/202108/lookinside/thumbnails/2182_10-1055-a-1492-2487-1.jpg)
No association has been reported between achalasia and gastroparesis despite similar pathophysiologic mechanisms and therapeutic options. A literature review shows only two reports of patients with both disorders for whom esophageal peroral endoscopic myotomy (POEM) and gastric (G-POEM) were performed. We have observed a number of patients with both conditions and question the possibility that their coexistence is not rare. We further propose a novel explanation for the increased incidence of gastroesophageal reflux disease (GERD) following treatment of achalasia.
Seven patients underwent POEM for achalasia with a resolution of dysphagia. A few months later, the patients developed symptoms of gastroparesis and new-onset GERD. G-POEM was performed successfully, and all patients had resolution or significant improvement in their GERD symptoms. Most patients were off proton pump inhibitors (PPIs) or using PPIs as needed only.
Concurrent or consecutive achalasia and gastroparesis raise the question of an alternative explanation for symptomatic GERD after POEM if the conditions either coexist or gastroparesis follow as a consequence of POEM by an unknown mechanism. In our patients, treatment of gastroparesis by G-POEM resolved reflux symptoms. Whether patients with achalasia have underlying, subclinical delayed gastric emptying is an important topic that warrants study and raises the question of performing gastric emptying study on all patients with achalasia before or after POEM.
Publication History
Received: 31 October 2020
Accepted: 03 February 2021
Article published online:
16 July 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Sadowski DC, Ackah F, Jiang B. et al. Achalasia: incidence, prevalence and survival. A population-based study. Neurogastroenterol Motil 2010; 22: e256-261
- 2 Rodriguez L, Irani K, Jiang H. et al. Clinical presentation, response to therapy, and outcome of gastroparesis in children. J Pediatr Gastroenterol Nutr 2012; 55: 185-190
- 3 Rey E, Choung RS, Schleck CD. et al. Prevalence of hidden gastroparesis in the community: the gastroparesis "iceberg". J Neurogastroenterol Motil 2012; 18: 34-42
- 4 Furness JB. The enteric nervous system and neurogastroenterology. Nature Rev Gastroenterol Hepatol 2012; 9: 286-294
- 5 Furuzawa-Carballeda J, Torres-Landa S, Valdovinos MA. et al. New insights into the pathophysiology of achalasia and implications for future treatment. World J Gastroenterol 2016; 22: 7892-7907
- 6 Moraveji S, Bashashati M, Elhanafi S. et al. Depleted interstitial cells of Cajal and fibrosis in the pylorus: Novel features of gastroparesis. Neurogastroenterol Motil 2016; 28: 1048-1054
- 7 Schlottmann F, Luckett DJ, Fine J. et al. Laparoscopic Heller Myotomy versus peroral endoscopic myotomy (POEM) for achalasia: a systematic review and meta-analysis. Ann Surgery 2018; 267: 451-460
- 8 Khashab MA, Sharaiha RZ, Saxena P. et al. Novel technique of auto-tunneling during peroral endoscopic myotomy (with video). Gastrointest Endosc 2013; 77: 119-122
- 9 Repici A, Fuccio L, Maselli R. et al. GERD after per-oral endoscopic myotomy as compared with Hellerʼs myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc 2018; 87: 934-943 e18
- 10 Nabi Z, Ramchandani M, Kotla R. et al. Gastroesophageal reflux disease after peroral endoscopic myotomy is unpredictable, but responsive to proton pump inhibitor therapy: a large, single-center study. Endoscopy 2020; 52: 643-651